X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs FDC LTD. - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH FDC LTD. STERLING BIOTECH/
FDC LTD.
 
P/E (TTM) x -0.4 17.0 - View Chart
P/BV x 0.0 2.3 0.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   FDC LTD.
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
FDC LTD.
Mar-18
STERLING BIOTECH/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs11319 3.3%   
Low Rs3164 2.1%   
Sales per share (Unadj.) Rs26.861.6 43.5%  
Earnings per share (Unadj.) Rs-15.09.9 -150.3%  
Cash flow per share (Unadj.) Rs-5.512.0 -45.7%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.973.2 75.0%  
Shares outstanding (eoy) m267.87174.40 153.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.33.9 6.6%   
Avg P/E ratio x-0.524.3 -1.9%  
P/CF ratio (eoy) x-1.320.2 -6.3%  
Price / Book Value ratio x0.13.3 3.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,86242,118 4.4%   
No. of employees `0001.45.5 24.5%   
Total wages/salary Rs m5472,167 25.2%   
Avg. sales/employee Rs Th5,303.31,943.7 272.8%   
Avg. wages/employee Rs Th403.8391.7 103.1%   
Avg. net profit/employee Rs Th-2,959.0313.7 -943.2%   
INCOME DATA
Net Sales Rs m7,18110,751 66.8%  
Other income Rs m43510 8.4%   
Total revenues Rs m7,22311,260 64.1%   
Gross profit Rs m9472,267 41.8%  
Depreciation Rs m2,543351 723.7%   
Interest Rs m4,37714 31,265.0%   
Profit before tax Rs m-5,9312,411 -246.0%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924671 -286.7%   
Profit after tax Rs m-4,0071,735 -230.9%  
Gross profit margin %13.221.1 62.5%  
Effective tax rate %32.427.8 116.6%   
Net profit margin %-55.816.1 -345.7%  
BALANCE SHEET DATA
Current assets Rs m14,3357,213 198.8%   
Current liabilities Rs m49,8092,104 2,367.7%   
Net working cap to sales %-494.047.5 -1,039.6%  
Current ratio x0.33.4 8.4%  
Inventory Days Days40354 740.3%  
Debtors Days Days17128 615.5%  
Net fixed assets Rs m55,4326,865 807.5%   
Share capital Rs m268175 152.9%   
"Free" reserves Rs m13,93512,586 110.7%   
Net worth Rs m14,70112,761 115.2%   
Long term debt Rs m9,4786 157,964.2%   
Total assets Rs m73,98815,041 491.9%  
Interest coverage x-0.4173.2 -0.2%   
Debt to equity ratio x0.60 137,117.4%  
Sales to assets ratio x0.10.7 13.6%   
Return on assets %0.511.6 4.3%  
Return on equity %-27.313.6 -200.4%  
Return on capital %-6.419.0 -33.9%  
Exports to sales %25.912.3 209.8%   
Imports to sales %0.20-   
Exports (fob) Rs m1,8601,327 140.2%   
Imports (cif) Rs m12NA-   
Fx inflow Rs m1,8601,889 98.5%   
Fx outflow Rs m250-   
Net fx Rs m1,8351,889 97.1%   
CASH FLOW
From Operations Rs m1,7191,498 114.7%  
From Investments Rs m-3,148201 -1,565.5%  
From Financial Activity Rs m1,426-1,694 -84.2%  
Net Cashflow Rs m-310 -33.0%  

Share Holding

Indian Promoters % 33.9 68.9 49.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.7 -  
FIIs % 9.9 7.5 132.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 19.0 206.8%  
Shareholders   21,482 23,730 90.5%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   GSK PHARMA  ASTRAZENECA PHARMA  DISHMAN PHARMA  IPCA LABS  JUBILANT LIFE SCIENCES  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex at New Highs, Jet Airways Suspends Operations - Your Inside Scoop of the Markets(Podcast)

Jet Airways, once India's largest private airline halted its operations indefinitely yesterday. The carrier flew its last scheduled flight from Amritsar to Mumbai yesterday.

Related Views on News

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

FDC LTD. Announces Quarterly Results (3QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Feb 15, 2019 | Updated on Feb 15, 2019

For the quarter ended December 2018, FDC LTD. has posted a net profit of Rs 437 m (up 2.5% YoY). Sales on the other hand came in at Rs 3 bn (up 1.4% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (2QFY19); Net Profit Down 33.6% (Quarterly Result Update)

Nov 23, 2018 | Updated on Nov 23, 2018

For the quarter ended September 2018, FDC LTD. has posted a net profit of Rs 431 m (down 33.6% YoY). Sales on the other hand came in at Rs 3 bn (down 12.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY18); Net Profit Down 35.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, FDC LTD. has posted a net profit of Rs 315 m (down 35.8% YoY). Sales on the other hand came in at Rs 3 bn (up 5.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - SUVEN LIFESCIENCES COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS